Kopylov, U., Hanzel, J., Liefferinckx, C., De Marco, D., Imperatore, N., Plevris, N., Baston‐Rey, I., Harris, R. J., Truyens, M., Domislovic, V., Vavricka, S., Biemans, V., Myers, S., Sebastian, S., Ben‐Horin, S., González Lama, Y., Gilletta, C., Ariella, B. S., Zelinkova, Z., Weisshof, R., Storan, D., Zittan, E., Farkas, K., Molnar, T., Franchimont, D., Cremer, A., Afif, W., Castiglione, F., Lees, C., Barreiro‐de Acosta, M., Lobaton, T., Doherty, G., Krznaric, Z., Pierik, M., Hoentjen, F., & Drobne, D. (2020). effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy. Alimentary pharmacology & therapeutics, 52(1), 135–142. http://access.bl.uk/ark:/81055/vdc_100102670809.0x00004f